Health Care & Life Sciences » Pharmaceuticals | Hisamitsu Pharmaceutical Co. Inc.

Hisamitsu Pharmaceutical Co. Inc. | Income Statement

Fiscal year is March-February. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
150,635
156,743
161,852
145,925
147,870
143,408
Cost of Goods Sold (COGS) incl. D&A
56,344
58,009
59,387
54,085
55,688
54,727
Gross Income
94,291
98,734
102,465
91,840
92,182
88,681
SG&A Expense
75,168
78,207
74,735
65,534
65,836
66,401
EBIT
19,123
20,527
27,730
26,306
26,346
22,280
Unusual Expense
5,000
900
-
1,863
1,023
138
Non Operating Income/Expense
1,098
1,718
51
1,091
1,783
2,133
Interest Expense
34
34
32
39
32
19
Pretax Income
33,727
29,416
27,922
29,984
27,694
25,673
Income Tax
12,167
10,432
9,993
9,443
8,367
6,294
Consolidated Net Income
21,560
18,984
17,929
20,541
19,327
19,378
Net Income
21,357
18,784
17,784
20,395
19,120
19,204
Net Income After Extraordinaries
21,357
18,784
17,784
20,395
19,120
19,204
Net Income Available to Common
21,357
18,784
17,784
20,395
19,119
19,204
EPS (Basic)
249.30
219.27
208.82
241.27
228.52
230.08
Basic Shares Outstanding
86
86
85
85
84
83
EPS (Diluted)
249.30
219.27
208.76
241.14
228.34
229.85
Diluted Shares Outstanding
86
86
85
85
84
84
EBITDA
26,615
28,140
36,275
33,674
32,351
28,022
Non-Operating Interest Income
84
104
184
292
493
800
Minority Interest Expense
203
200
145
146
207
174
Equity in Affiliates (Pretax)
8,456
6,201
11
471
129
619

About Hisamitsu Pharmaceutical Co.

View Profile
Address
408 Tashiro Daikan-machi
Tosu Saga 841
Japan
Employees -
Website http://www.hisamitsu.co.jp
Updated 07/08/2019
Hisamitsu Pharmaceutical Co., Inc. engages in the research, development, manufacture, and sale of pharmaceuticals and related products. Its products are sold under Salonpas, Salonsip, Mohrus, ByeBye-Fever, Lifecella, and Keplat brands. It also provides ethical pharmaceuticals, over the counter drugs, medical devices, health supplements, and topical analgesic products.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.